<DOC>
	<DOCNO>NCT00632619</DOCNO>
	<brief_summary>This study evaluate effectiveness integrative group psychosocial therapy combine stimulant medication treat child attention deficit hyperactivity disorder plus impairment mood .</brief_summary>
	<brief_title>Group-Based Behavioral Therapy Combined With Stimulant Medication Treating Children With Attention Deficit Hyperactivity Disorder Impaired Mood</brief_title>
	<detailed_description>There increase recognition many child attention deficit hyperactivity disorder ( ADHD ) exhibit depressive manic-like symptom suggestive major depressive disorder ( MDD ) bipolar disorder ( BP ) . Many child ADHD plus impairment mood display symptom irritability , affective instability , reactive aggression , typically lack hallmark symptom , extreme mood cycle sustain depressed mood , lead BD MDD diagnosis . Significant debate exist whether child true comorbid mood disorder , make treatment mood symptom ADHD child controversial . ADHD traditionally treat stimulant medication and/or behavior modification therapy . However , little known safety stimulant ADHD child manic symptom . Also , treatment exist design simultaneously improve ADHD mood problem child . Psychosocial treatment hold particular promise ADHD child impairment mood well-studied pediatric treatment little risk worsen mood symptom . This study develop integrative psychosocial treatment include aspect cognitive behavioral therapy ( CBT ) psychoeducational technique pediatric adult mood disorder . The study evaluate effectiveness integrative psychosocial treatment , call group behavior therapy , combine stimulant medication improve mood enhance treatment response child ADHD impairment mood . Participation study last 5 6 month . All eligible participant begin treatment stimulant medication 2 6 week , optimal medication dosage determine . During medication dose phase , study staff collect weekly rating child participant 's behavior home school , participant see weekly study doctor monitor medication dosage . Upon achieve optimal dose , child participant answer question mood behavior . Participants still exhibit mood problem assign randomly receive 12 week either group behavior therapy community-based psychosocial treatment , still continue prescribed medication . Group behavior therapy session child participant focus improve mood ability maintain friendship , practice way well control emotion , learn effective problem solve skill . Child participant also give weekly homework assignment practice learn therapy skill . Group behavior therapy session parent participant teach parent way identify address child 's mood problem , communicate good child , work school staff address academic behavioral problem . Participants assign community-based psychosocial treatment receive counseling service part study , refer community service . Every 6 week therapy phase , participant answer repeat question mood behavior . Six week complete therapy phase , participant return final follow-up visit , include repeat question , rating child participant 's mood symptom , meet study doctor check medication .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>ADHD combine subtype evidence depressive maniclike symptom , assess CDRS , YMRS , Washington University St. Louis Kiddie Schedule Affective Disorders Schizophrenia , persist stimulant treatment Full Scale IQ le 80 Current seizure disorder history seizures require treatment significant neurological problem History medical problem stimulant treatment may involve considerable risk , include cardiac arrhythmia , hypertension , Tourette 's disorder , history severe tic exacerbation cause stimulant exposure ( Note : child uncomplicated tic disorder family history tic disorder exclude stimulant well tolerate majority case ) Meets full criterion Type I II bipolar disorder child manifest mood symptom ( manic depressive ) , significant suicidal ideation psychotic symptom require emergent pharmacological treatment hospitalization History concurrent diagnosis follow disorder : pervasive developmental disorder , schizophrenia psychotic disorder , posttraumatic stress disorder , sexual disorder , organic mental disorder , eat disorder No longer manifest impair manic/depressive symptom stimulant therapy base CDRSR great 27 YMRS great 11 Clinical Global ImpressionsSeverity 3 great</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Subthreshold Manic States Children</keyword>
	<keyword>ADHD</keyword>
</DOC>